• OPEN AN ACCOUNT
Indian Indices
Nifty
24,971.90 -140.50
(-0.56%)
Sensex
81,896.79 -511.38
( -0.62%)
Bank Nifty
56,059.35 -193.50
( -0.34%)
Nifty IT
38,414.10 -577.35
( -1.48%)
Global Indices
Nasdaq
42,233.20 40.53
(0.10%)
Dow Jones
5,989.55 -12.32
(-0.21%)
Hang Seng
38,330.35 -72.88
(-0.19%)
Nikkei 225
8,774.65 -17.15
(-0.20%)
Forex
USD-INR
86.67 0.24
(0.27%)
EUR-INR
99.45 0.06
(0.06%)
GBP-INR
116.39 0.20
(0.17%)
JPY-INR
0.60 0.00
(-0.02%)

EQUITY - MARKET SCREENER

Beta Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
535022
INE351Y01019
127.8259206
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BETA
95.48
1790.77
EPS(TTM)
Face Value()
Div & Yield %
18.58
10
0
 

Aanchal Ispat reports standalone net loss of Rs 13.05 crore in the March 2025 quarter
May 31,2025
Net loss of Aanchal Ispat reported to Rs 13.05 crore in the quarter ended March 2025 as against net profit of Rs 1.21 crore during the previous quarter ended March 2024. Sales declined 26.79% to Rs 34.60 crore in the quarter ended March 2025 as against Rs 47.26 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 13.40 crore in the year ended March 2025 as against net loss of Rs 6.25 crore during the previous year ended March 2024. Sales rose 38.21% to Rs 151.13 crore in the year ended March 2025 as against Rs 109.35 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales34.6047.26 -27 151.13109.35 38
OPM %-13.82-1.40 --3.22-3.15 -
PBDT-4.750.07 PL -4.72-6.91 32
PBT-5.01-0.08 -6163 -5.36-7.54 29
NP-13.051.21 PL -13.40-6.25 -114